A poor cancer prognosis is determined by changes in acute-phase proteins (elevated CRP and hypoalbuminemia) and white blood cell counts (elevated neutrophil count and low lymphocyte count) of the systemic inflammatory response (31). This evidence concerns the gene CRP and cancer.